A detailed history of Hantz Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 47,845 shares of ABBV stock, worth $8.61 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
47,845
Previous 49,340 3.03%
Holding current value
$8.61 Million
Previous $8.46 Million 11.64%
% of portfolio
0.17%
Previous 0.16%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $244,940 - $297,998
-1,495 Reduced 3.03%
47,845 $9.45 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $7.64 Million - $8.92 Million
49,340 New
49,340 $8.46 Million
Q1 2024

Aug 06, 2024

SELL
$159.82 - $182.1 $540,830 - $616,226
-3,384 Reduced 6.16%
51,577 $9.39 Million
Q4 2023

Aug 06, 2024

SELL
$137.6 - $154.97 $517,788 - $583,152
-3,763 Reduced 6.41%
54,961 $8.52 Million
Q3 2023

Aug 06, 2024

BUY
$133.59 - $154.65 $53,168 - $61,550
398 Added 0.68%
58,724 $8.75 Million
Q2 2023

Aug 06, 2024

BUY
$132.51 - $164.9 $20,804 - $25,889
157 Added 0.27%
58,326 $7.86 Million
Q1 2023

Aug 06, 2024

BUY
$144.61 - $166.54 $81,849 - $94,261
566 Added 0.98%
58,169 $9.27 Million
Q4 2022

Aug 06, 2024

BUY
$138.31 - $165.87 $514,236 - $616,704
3,718 Added 6.9%
57,603 $9.31 Million
Q3 2022

Aug 06, 2024

BUY
$134.21 - $153.93 $159,307 - $182,714
1,187 Added 2.25%
53,885 $7.23 Million
Q2 2022

Aug 06, 2024

BUY
$137.62 - $174.96 $319,278 - $405,907
2,320 Added 4.61%
52,698 $8.07 Million
Q1 2022

Aug 06, 2024

SELL
$131.98 - $163.75 $2.1 Million - $2.61 Million
-15,940 Reduced 24.04%
50,378 $8.17 Million
Q4 2021

Aug 06, 2024

SELL
$107.43 - $135.93 $7,520 - $9,515
-70 Reduced 0.11%
66,318 $8.98 Million
Q3 2021

Aug 06, 2024

BUY
$106.4 - $120.78 $1.02 Million - $1.16 Million
9,599 Added 16.9%
66,388 $7.16 Million
Q2 2021

Aug 06, 2024

BUY
$105.21 - $117.21 $284,277 - $316,701
2,702 Added 5.0%
56,789 $6.4 Million
Q1 2021

Aug 06, 2024

BUY
$102.3 - $112.62 $485,618 - $534,607
4,747 Added 9.62%
54,087 $5.85 Million
Q4 2020

Aug 06, 2024

SELL
$80.49 - $108.67 $18,190 - $24,559
-226 Reduced 0.61%
36,775 $3.94 Million
Q3 2020

Aug 06, 2024

SELL
$85.91 - $100.83 $66,580 - $78,143
-775 Reduced 2.05%
37,001 $3.24 Million
Q2 2020

Aug 06, 2024

BUY
$73.37 - $98.18 $58,622 - $78,445
799 Added 2.16%
37,776 $3.71 Million
Q1 2020

Aug 06, 2024

SELL
$64.5 - $97.79 $797,413 - $1.21 Million
-12,363 Reduced 25.06%
36,977 $2.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.